Inflammatory Bowel Disease Treatment Market Size by Type (Ulcerative Colitis, Crohn's Disease), Drug Class (Corticosteroids, Aminosalicylates, TNF inhibitors, Anti-integrin, IL inhibitors, JAK inhibitors, Others), Distribution Channel, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2030

Base Year: 2020 Historical Data: 2018-19

Report ID: TBI-12607
Published Date: Nov, 2021
Pages: 234
Category: Healthcare
Format: PDF

Buy @ $4700.00 Request Sample PDF

Segment Analysis

The global inflammatory bowel disease treatment market has been segmented based on type, drug class, distribution channel and regions.

The type segment is divided into ulcerative colitis, crohn's disease. The Crohn's disease segment dominated the market with around 62% in 2020. Throughout the forecast period, the segment is expected to dominate the market. Factors propelling the market for inflammatory bowel disease treatment include a high prevalence rate, rising biologic prescription rates, and the high cost of Crohn's disease treatment. According to the Crohn's and Colitis Foundation, biologics are prescribed to about 25% of Crohn's disease patients in the United States. Also, the prevalence of Crohn's disease is around 319/100,000 people in North America and 322/100,000 people in Europe, respectively.
The drug class segment includes corticosteroids, aminosalicylates, JAK inhibitors, TNF inhibitors, anti-integrin, IL inhibitors, others. The TNF inhibitors segment led the market with a market share around 48% in 2020. During the forecast period, the segment is expected to dominate the market. The high rate of prescription of TNF inhibitors like Remicade and Humira, as well as the efficacy of medications for IBD, are expected to boost demand during the forecast period.
By distribution channel, the market is segmented into retail pharmacy hospital pharmacy and online pharmacy. The hospital pharmacy segment led the market with a market share around 44% in 2020. The rising prevalence of ulcerative colitis and Crohn's disease has resulted in an increase in hospital admissions. The development of the hospital pharmacy segment in the inflammatory bowel disease treatment market is further aided by the established infrastructure of hospitals and the ease with which treatment is available.

Regional Segmentation Analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region emerged as the largest market for the Inflammatory Bowel Disease Treatment market with around 51.5% share of the market revenue in 2020.

Over the forecast period, the region is anticipated to grow at a lucrative rate. An increase in the prescription of novel drugs, better reimbursement policies and high treatment rates in the region are all contributing to the region's market growth.
With an exponential rise in the patient population, Asia-Pacific is predicted to be the fastest-growing inflammatory bowel disease treatment market. In Asia-Pacific, developing countries like Japan and China are expected to be the main markets for inflammatory bowel disease treatment. The increased prevalence of stress disorders and anxiety, as well as consumers' sedentary lifestyles, are likely to result in an increase in the patient pool, driving up the demand for treatment medications. Furthermore, during the projected period, reasonably soft drug regulatory policies and increased government activities aimed at healthcare development are expected to boost market growth.

North America Inflammatory Bowel Disease Treatment Market Share in 2020 - 51.5%

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Get Your Report Customized

Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
Segmentation on the basis of any specific country or region
Any segment can be classified on the basis of application
Application segment can be further divided on the basis of companies
The companies profiled are not limited, we can incorporate additional companies of your choice
We can split the company market share on the basis of product, application and region
Report can be prepared for any specific country/region/segment
Customers can be added on the basis of regions and countries

Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis ByType
          4.3.2. Market Attractiveness Analysis ByDrug class
          4.3.3. Market Attractiveness Analysis ByDistribution channel
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising prevalence of ulcerative colitis and Crohn’s disease
          5.2.2. Medical technology advancements
    5.3. Restraints
          5.3.1. Higher costs
    5.4. Opportunities
          5.4.1. Biosimilars are getting more approval
    5.5. Challenges
          5.5.1. Covid-19 impact

6. Global Inflammatory bowel disease treatment Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Ulcerative Colitis
    6.3. Crohn’s Disease

7. Global Inflammatory bowel disease treatment Market Analysis and Forecast, By Drug class
    7.1. Segment Overview
    7.2. Corticosteroids
    7.3. Aminosalicylates
    7.4. TNF inhibitors
    7.5. Anti-integrin
    7.6. IL inhibitors
    7.7. JAK inhibitors
    7.8. Others

8. Global Inflammatory bowel disease treatment MarketAnalysis and Forecast, By Distribution channel
    8.1. Segment Overview
    8.2. Retail pharmacy
    8.3. Hospital pharmacy
    8.4. Online pharmacy

9. Global Inflammatory bowel disease treatment MarketAnalysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Inflammatory bowel disease treatment Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in GlobalInflammatory bowel disease treatment Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Abbott Laboratories
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. AbbVie Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Agilent Technologies, Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Alkem Laboratories Limited
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Allergan plc
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. B&W Tek
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Biogen Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Celgene Corporation
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Celltrion Healthcare
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Cosmo Pharmaceuticals
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Gilead Sciences
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Innovate Biopharmaceuticals
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Janssen Biotech Inc.
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. Johnson & Johnson Services Inc.
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Novartis AG
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. Pfizer Inc.
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis
    11.17. PG Instruments Limited
          11.17.1. Business Overview
          11.17.2. Company Snapshot
          11.17.3. Company Market Share Analysis
          11.17.4. Company Product Portfolio
          11.17.5. Recent Developments
          11.17.6. SWOT Analysis
    11.18. Takeda Pharmaceutical Company Limited
          11.18.1. Business Overview
          11.18.2. Company Snapshot
          11.18.3. Company Market Share Analysis
          11.18.4. Company Product Portfolio
          11.18.5. Recent Developments
          11.18.6. SWOT Analysis
    11.19. UCB Inc
          11.19.1. Business Overview
          11.19.2. Company Snapshot
          11.19.3. Company Market Share Analysis
          11.19.4. Company Product Portfolio
          11.19.5. Recent Developments
          11.19.6. SWOT Analysis
    11.20. Valeant Pharmaceuticals International
          11.20.1. Business Overview
          11.20.2. Company Snapshot
          11.20.3. Company Market Share Analysis
          11.20.4. Company Product Portfolio
          11.20.5. Recent Developments
          11.20.6. SWOT Analysis

List of Table

1.Global Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

2.Global Ulcerative Colitis Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

3.Global Crohn’s Disease Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

4.Global Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

5.Global CorticosteroidsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

6.Global Aminosalicylates, Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

7.Global TNF inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

8.Global Anti-integrinInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

9.Global IL inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

10.Global JAK inhibitorsInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

11.Global Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

12.GlobalRetail pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

13.Global Hospital pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

14.Global Online pharmacyInflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

15.Global Inflammatory bowel disease treatment Market, By Region, 2018–2030 (USD Billion)

16.Global Inflammatory bowel disease treatment Market, By North America, 2018–2030 (USD Billion)

17.North America Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

18.North America Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

19.North America Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

20.U.S. Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

21.U.S. Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

22.U.S. Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

23.Canada Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

24.Canada Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

25.Canada Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

26.Mexico Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

27.Mexico Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

28.Mexico Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

29.Europe Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

30.Europe Inflammatory bowel disease treatment Market, By Drug class,2018–2030 (USD Billion)

31.Europe Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

32.Germany Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

33.Germany Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

34.Germany Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

35.France Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

36.France Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

37.France Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

38.U.K. Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

39.U.K. Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

40.U.K. Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

41.Italy Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

42.Italy Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

43.Italy Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

44.Spain Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

45.Spain Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

46.Spain Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

47.Asia Pacific Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

48.Asia Pacific Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

49.Asia Pacific Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

50.Japan Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

51.Japan Inflammatory bowel disease treatment Market, By Drug clas,2018–2030 (USD Billion)

52.Japan Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

53.China Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

54.China Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

55.China Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

56.India Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

57.India Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

58.India Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

59.South America Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

60.South America Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

61.South America Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

62.Brazil Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

63.Brazil Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

64.Brazil Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

65.Middle East and Africa Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

66.Middle East and Africa Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

67.Middle East and Africa Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

68.UAE Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

69.UAE Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

70.UAE Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

71.South Africa Inflammatory bowel disease treatment Market, By Type, 2018–2030 (USD Billion)

72.South Africa Inflammatory bowel disease treatment Market, By Drug class, 2018–2030 (USD Billion)

73.South Africa Inflammatory bowel disease treatment Market, By Distribution channel, 2018–2030 (USD Billion)

List of Figures

1. Global Inflammatory bowel disease treatment market segmentation

2. Inflammatory bowel disease treatment Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis

7. Value Chain Analysis

8. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByType

9. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByDrug class

10. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis ByDistribution channel

11. Global Inflammatory bowel disease treatment MarketAttractiveness Analysis By Region

12. Global Inflammatory bowel disease treatment Market: Dynamics

13.Global Inflammatory bowel disease treatment MarketShare ByType (2021 & 2030)

14. Global Inflammatory bowel disease treatment MarketShare By Drug class (2021 & 2030)

15. Global Inflammatory bowel disease treatment MarketShare By Distribution channel(2021 & 2030)

16. Global Inflammatory bowel disease treatment MarketShare by Regions (2021 & 2030)

17.Global Inflammatory bowel disease treatment MarketShare by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2030. The Brainy Insights has segmented the global Inflammatory Bowel Disease Treatment market on the basis of below-mentioned segments:

Global Inflammatory Bowel Disease Treatment Market by Type:

Ulcerative Colitis
Crohn's Disease

Global Inflammatory Bowel Disease Treatment Market by Drug Class:

Corticosteroids
Aminosalicylates
TNF inhibitors
Anti-integrin
IL inhibitors
JAK inhibitors
Others

Global Inflammatory Bowel Disease Treatment Market by distribution Channel:

Retail pharmacy
Hospital pharmacy
Online pharmacy

Global Inflammatory Bowel Disease Treatment Market by Region:

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
Asia-Pacific
- Japan
- China
- India
South America
- Brazil
Middle East and Africa
- UAE
- South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations.
We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:

Import & Export Data
Business Trade Information
Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

Evaluating the penetration level and usage rates of the product.
Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

Applying demographic along with psychographic segmentation for market evaluation
Determining the Micro and Macro-economic indicators for each region
Examining the industry indicators prevailing in the market.

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

CXOs and VPs of leading companies’ specific to sector
Purchasing managers, technical personnel, end-users
Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Choose License Type

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date

Inflammatory Bowel Disease Treatment Market